Clinical trial • Other
Dexmedetomidine for General anaesthesia (outpatient surgery)
Clinical trial of Dexmedetomidine for General anaesthesia (outpatient surgery). 594 participants.
Overview
- Trial Therapeutic Area
- Other
- Trial Disease
- General anaesthesia (outpatient surgery)
- Drug Modality
- Small molecule
Key dates
- Initial CTIS Submission Date
- 06-09-2024
- First CTIS Authorization Date
- 03-10-2024
Trial design
Clinical trial across 1 site in France.
- Target Sample Size
- 594
Eligibility
Recruits 594 Vulnerable population not selected; no consent/assent details available in the record..
- Vulnerable Population
- Vulnerable population not selected; no consent/assent details available in the record.
Recruitment
- Planned Sample Size
- 594
- Recruitment Window Months
- 50
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 594
France
- Earliest CTIS Part Ii Submission Date
- 16-09-2024
- Latest Decision Or Authorization Date
- 06-02-2026
- Processing Time Days
- 508
- Number Of Sites
- 1
- Number Of Participants
- 594
Sites
- Site Name
- Centre Hospitalier Universitaire De Nimes
- Department Name
- Anesthésie
- Contact Person Name
- Yann GRICOURT
- Contact Person Email
- yann.gricourt@chu-nimes.fr
Sponsor
Primary sponsor
- Full Name
- Centre Hospitalier Universitaire De Nimes
- Organisation Type
- Hospital/Clinic/Other health care facility
- Country Of Registered Address
- France
Investigational products
- Investigational Product Name
- Dexmedetomidine
- Active Substance
- Dexmedetomidine
- Modality
- Small molecule
Related trials
Other published trials that may interest you.